You are using an older browser version. Please use a supported version for the best MSN experience.

CELLECTAR BIOSCIENCES, INC.

NASDAQ: CLRB
=
1.40
0.00
0.00%
  • Key statistics
  • Growth
  • Profitability
  • Price ratios
Industry Pharmaceuticals
Highlights
Analyst Recommendation: Strong Buy
    • Revenue

    • 0

    • Net Income

    • -14.09M

    • Market Cap.

    • 33.60M

    • Enterprise Value

    • 27.65M

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.86

    • Forward P/E

    • -1.32

    • Price/Sales

    • 0.00

    • Price/Book Value

    • 1.66

    • Price/Cash flow

    • -

      • EBITDA

      • -14.05M

      • Return on Capital %

      • -135.87

      • Return on Equity %

      • -237.40

      • Return on Assets %

      • -135.87

      • Book Value/Share

      • 0.56

      • Shares Outstanding

      • 24.00M

      • Last Split Factor (Date)

      • 1:10 (7/17/2018)

      • Last Dividend (Ex-Date)

      • 0.00 (-)

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      8/8/2020
      Strong Buy
        • 1 Year Price Target

        • 5.50

        • Analysts

        • 1

        • EPS Estimate

        • -0.93

        • Cashflow Estimate

        • -

        Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

        • Sales (Revenue)

          Q/Q (Last Year)

        • -

        • 7.27

        • Net Income

          YTD/YTD (Last Year)

        • 8.97

        • -6.39

        • Net Income

          Q/Q (Last Year)

        • -9.28

        • 6.51

        • Sales (Revenue)

          5-Year Annual Average

        • -

        • -

        • Net Income

          5-Year Annual Average

        • -

        • -

        • Dividends

          5-Year Annual Average

        • -

        • -

        • Profit Margins (%)

        • Company

        • Industry

        • Gross Margin

        • -

        • 62.52

        • Pre-Tax Margin

        • -

        • 15.14

        • Net Profit Margin

        • -

        • 12.52

        • Average Gross Margin

          5-Year Annual Average

        • -

        • 62.55

        • Average Pre-Tax Margin

          5-Year Annual Average

        • -

        • 16.03

        • Average Net Profit Margin

          5-Year Annual Average

        • -

        • 13.09

        • Price Ratios

        • Company

        • Industry

        • Current P/E Ratio

        • -

        • -

        • P/E Ratio 5-Year High

        • -

        • -

        • P/E Ratio 5-Year Low

        • -

        • -

        • Price/Sales Ratio

        • -

        • 3.79

        • Price/Book Value

        • 1.66

        • 4.15

        • Price/Cash Flow Ratio

        • -

        • 16.15

        Current Historical
        • Financial health
        • Trading statistics
        • Management effectiveness
        Industry Pharmaceuticals
        • Financial Ratios

        • Company

        • Industry

        • Debt/Equity Ratio

        • 0.00

        • 0.76

        • Current Ratio

        • 2.58

        • 1.50

        • Quick Ratio

        • -

        • 1.14

        • Leverage Ratio

        • 1.66

        • 2.51

        • Book Value/Share

        • 0.56

        • 2.35

        • Key Metrics

        • Company

          • Shares Short

            as of -

          • -

          • Short Ratio

            as of -

          • -

          • Short % of Float

            as of -

          • -

          • Shares Short

            prior month

          • -

          • Trailing Annual Dividend Yield

          • -

          • 5 Year Average Dividend Yield

          • 0.00

          • Key Metrics

          • Company

            • Payout Ratio

            • -

            • Dividend Date

            • -

            • Ex-Dividend Date

            • -

            • Last Split Factor

              new per old

            • 1:10

            • Last Split Date

            • 7/17/2018

            • Key Metrics

            • Company

            • Industry

            • Return on Equity %

              (5-Year Average)

            • -237.40

              (-133.60)

            • 14.34

              (13.86)

            • Return on Assets %

              (5-Year Average)

            • -135.87

              (-82.55)

            • 7.06

              (6.15)

            • Return on Capital %

              (5-Year Average)

            • -180.50

              (-109.28)

            • 7.80

              (8.04)

            • Income/Employee

            • -

            • 19.33k

            • Inventory Turnover

            • -

            • 2.22

            • Asset Turnover

            • 0.00

            • 0.46

            Current Historical
            AdChoices
            AdChoices
            AdChoices
            image beaconimage beaconimage beacon